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and to promote intestinal homeostasis (Artis, 
2008; Hooper and Macpherson, 2010; Fung 
et al., 2014; Peterson and Artis, 2014). Defects 
in epithelial barrier function are associated with 
multiple infectious and inflammatory diseases, 
including inflammatory bowel disease (IBD; 
Pasparakis, 2008; Marchiando et al., 2010; Maloy 
and Powrie, 2011), and recent studies have high-
lighted a critical role for innate lymphoid cells 
(ILCs) in regulating immunity, inflammation, 
and tissue repair at barrier surfaces such as the 
intestine (Spits and Cupedo, 2012; Walker et al., 
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Innate lymphoid cells (ILCs) are critical for maintaining epithelial barrier integrity at mucosal 
surfaces; however, the tissue-specific factors that regulate ILC responses remain poorly charac-
terized. Using mice with intestinal epithelial cell (IEC)–specific deletions in either inhibitor of 
B kinase (IKK) or IKK, two critical regulators of NFB activation, we demonstrate that IEC-
intrinsic IKK expression selectively regulates group 3 ILC (ILC3)–dependent antibacterial 
immunity in the intestine. Although IKKIEC mice efficiently controlled Citrobacter rodentium 
infection, IKKIEC mice exhibited severe intestinal inflammation, increased bacterial dissemina-
tion to peripheral organs, and increased host mortality. Consistent with weakened innate immu-
nity to C. rodentium, IKKIEC mice displayed impaired IL-22 production by RORt+ ILC3s, and 
therapeutic delivery of rIL-22 or transfer of sort-purified IL-22–competent ILCs from control 
mice could protect IKKIEC mice from C. rodentium–induced morbidity. Defective ILC3 re-
sponses in IKKIEC mice were associated with overproduction of thymic stromal lymphopoietin 
(TSLP) by IECs, which negatively regulated IL-22 production by ILC3s and impaired innate 
immunity to C. rodentium. IEC-intrinsic IKK expression was similarly critical for regulation of 
intestinal inflammation after chemically induced intestinal damage and colitis. Collectively, 
these data identify a previously unrecognized role for epithelial cell–intrinsic IKK expression 
and TSLP in regulating ILC3 responses required to maintain intestinal barrier immunity.
© 2015 Giacomin et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ 
by-nc-sa/3.0/).
Maintenance of epithelial barrier integrity at 
mucosal surfaces is essential to limit exposure 
to commensal and pathogenic microorganisms 
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2011; Bonnegarde-Bernard et al., 2014; Takahashi et al., 
2014; Vereecke et al., 2014). Although ILC3s are known to 
regulate IEC function via IL-17A and IL-22 expression (Aujla 
et al., 2008; Zheng et al., 2008; Hanash et al., 2012; Muñoz 
et al., 2015), whether tissue-resident nonhematopoietic cells 
such as IECs can reciprocally regulate intestinal ILC3 re-
sponses remains incompletely defined. In the present study, 
we demonstrate that mice with IEC-specific deletions in 
IKK, but not IKK, exhibit impaired innate immunity to 
C. rodentium infection, identifying a previously unappreciated 
role for the noncanonical NFB activation pathway in anti-
bacterial immunity. Critically, mice with IEC-intrinsic IKK 
deletions displayed impaired IL-22 production by RORt+ 
ILC3s and delivery of recombinant IL-22 or IL-22–competent 
sort-purified ILCs was sufficient for restoration of protection 
against C. rodentium infection. IEC-intrinsic IKK was also 
critical for regulation of intestinal inflammation after chemi-
cally induced intestinal damage and colitis. Mechanistically, 
the absence of IKK expression resulted in elevated thymic 
stromal lymphopoietin (TSLP) production by colonic epithelial 
cells, which negatively regulated IL-22 production by ILC3s 
in vitro and innate immunity to C. rodentium in vivo. Further-
more, neutralization of TSLP in IKKIEC mice could partially 
restore ILC3 responses and innate immunity to C. rodentium. 
Collectively, these data highlight a previously unrecognized 
mechanism by which IECs and ILC3s reciprocally regulate 
intestinal immune homeostasis.
RESULTS
IEC-intrinsic IKK, but not IKK, expression is critical  
for immunity to C. rodentium infection
C. rodentium is a natural gram-negative extracellular bacterial 
pathogen of mice akin to the human pathogen enterohemor-
rhagic Escherichia coli that causes NFB activation and colonic 
lesions after attachment to the epithelial surface (Mundy et al., 
2005; Wang et al., 2006; Chandrakesan et al., 2010). Innate 
immunity to C. rodentium and regulation of intestinal barrier 
integrity is controlled, in part, by ILC3-dependent IL-22 re-
sponses (Satoh-Takayama et al., 2008; Zheng et al., 2008; Kiss 
et al., 2011; Sonnenberg et al., 2011b; Tumanov et al., 2011). 
However, the function of IEC-intrinsic NFB activation and 
whether it regulates antibacterial immunity and tissue-protective 
ILC responses is unknown. Using mice with IEC-specific 
deletions in either IKK or IKK, respectively, we assessed 
whether IEC-intrinsic canonical versus noncanonical NFB 
activation regulates intestinal ILC responses. To do so, IKKF/F 
or IKKF/F mice in which either the Ikk or Ikk genes are 
flanked by LoxP sites were crossed with mice expressing Cre 
recombinase under control of the IEC-specific villin promoter 
to generate IEC-specific IKK (IKKIEC) or IKK (IKKIEC) 
knockout mice, as described previously (Nenci et al., 2007). 
Deletion of IKK in IECs from IKKIEC mice and IKK in 
IECs from IKKIEC mice was confirmed by Western blot-
ting (Fig. 1 a). To examine the potential influence of IECs on 
the functions of ILCs under inflammatory conditions, we in-
fected IKKIEC, IKKIEC, and littermate control mice with 
2013; McKenzie et al., 2014; Sonnenberg, 2014; Artis and 
Spits, 2015). ILCs represent a heterogeneous family of cells 
that, based on their expression of the transcription factors T-bet, 
GATA3, and RORt, can be categorized into three groups 
with diverse effector functions. Group 1 ILCs (ILC1s) express 
IFN and T-bet and include NK cells (Spits and Cupedo, 
2012), whereas ILC2s express GATA3, ROR, MHCII, IL-5, 
IL-13, and amphiregulin and regulate inflammation, barrier 
integrity, and/or tissue homeostasis in the skin, intestine, lung, 
and adipose tissue (Neill et al., 2010; Monticelli et al., 2011; 
Molofsky et al., 2013; Roediger et al., 2013; Oliphant et al., 
2014; Brestoff et al., 2015; Lee et al., 2015). RORt+ ILC3s 
express IL-17A, IFN, MHCII, lymphotoxin (LT)12, and 
IL-22 and promote antibacterial immunity, secondary lym-
phoid structure formation, and the regulation of intestinal in-
flammation (Buonocore et al., 2010; Kiss et al., 2011; Tumanov 
et al., 2011; Sonnenberg et al., 2012; Hepworth et al., 2013, 
2015; Goto et al., 2014). Although IL-17A and IFN pro-
duction by ILC1s or ILC3s is implicated in the pathogenesis 
of colitis (Buonocore et al., 2010; Geremia et al., 2011; Spits 
and Di Santo, 2011), ILC3-derived IL-22 is associated with the 
promotion of epithelial barrier integrity at multiple tissue sites 
(Aujla et al., 2008; Satoh-Takayama et al., 2008; Sonnenberg 
et al., 2012; Goto et al., 2014). Ligation of the IL-22 recep-
tor, expression of which is restricted to nonhematopoietic cell 
lineages such as epithelial cells, induces expression of host de-
fense genes, mucins, and antimicrobial peptides (AMPs) that 
are critical for host-protective immunity after exposure to vi-
ruses and bacterial infections such as Klebsiella pneumoniae and 
Citrobacter rodentium (Aujla et al., 2008; Zheng et al., 2008; Kim 
et al., 2012; Klatt et al., 2012; Ivanov et al., 2013; Goto et al., 
2014; Zhang et al., 2014; Muñoz et al., 2015). Although the 
influence of RORt+ ILC3s on epithelial barrier function is 
well characterized, the molecular and cellular pathways that 
regulate ILC responses in mucosal tissue microenvironments 
remain poorly understood.
In addition to providing a physical barrier to microorgan-
isms, intestinal epithelial cells (IECs) express cytokines, che-
mokines, pattern recognition receptors, inflammasomes, and 
AMPs that permit cross-talk with mucosal immune cells and 
maintenance of immune homeostasis (Strober, 1998; Pasparakis, 
2008; Rescigno, 2011; Welz et al., 2011; Goto and Ivanov, 
2013; Dannappel et al., 2014; Kagnoff, 2014; Peterson and 
Artis, 2014). For example, signals derived from IECs regulate 
proinflammatory cytokine secretion by DCs (Nenci et al., 2007; 
Zaph et al., 2007), enhancing their ability to promote regula-
tory and TH2-cytokine responses (Rimoldi et al., 2005a,b; 
Iliev et al., 2009). IECs also secrete cytokines that regulate 
macrophage function (Smythies et al., 2005) and B cell pro-
duction of secretory IgA (Xu et al., 2007; Cerutti, 2008). 
Genetic approaches to interrogate the factors that regulate IEC 
function have identified a critical role for NFB-associated 
genes, including inhibitor of B kinase (IKK) or IKK, which 
control “canonical” versus “noncanonical” NFB-dependent 
gene expression, respectively (Greten et al., 2004; Nenci et al., 
2007; Zaph et al., 2007; Eckmann et al., 2008; Vlantis et al., 
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with IKKF/F controls (Fig. 1, c and d). Associated with an 
impaired ability to control C. rodentium infection, IKKIEC, 
but not IKKIEC, mice displayed exacerbated infection-induced 
weight loss (Fig. 1 e), and 50% of IKKIEC mice succumbed 
to infection by day 11 p.i. (Fig. 1 f). IKKIEC mice that 
C. rodentium. Although IKKIEC mice exhibited equivalent 
fecal C. rodentium burdens to IKKF/F mice at day 5 postinfec-
tion (p.i.), IKKIEC mice displayed higher fecal bacterial titers 
(Fig. 1 b) and enhanced bacterial dissemination to peripheral 
organs, including the spleen and liver at day 11 p.i. compared 
Figure 1. IEC-intrinsic IKK, but not IKK, 
expression is critical for immunity to C. roden-
tium infection. (a) IKK and IKK expression in IECs 
from naive IKKF/F, IKKF/F, IKKIEC, and IKKIEC 
mice as detected by Western blot. (b–j) Littermate 
control IKKF/F and IKKF/F mice and mutant 
IKKIEC and IKKIEC mice were infected with  
C. rodentium. (b–d) C. rodentium CFU in the feces on 
day 5 p.i. (b), spleen on day 11 p.i. (c), and liver on 
day 11 p.i. (d). (e and f) Percentage of initial body 
weight (e) and percent survival (f) at the indicated 
time points p.i. (g) H&E staining of colon tissue 
sections from naive mice. (h) H&E staining of colon 
tissue sections from C. rodentium–infected mice at 
day 11 p.i., including high-magnification insets (bot-
tom). (i) Pathological score of colon histology. (j) H&E 
staining of liver tissue sections of day 11 infected 
mice. Arrows indicate neutrophil-rich inflammatory 
foci. All bars, 50 µm. Data for a are representative of 
two independent experiments using pooled IECs 
from three mice. Data for b–j are representative of 
three to four independent experiments (IKKF/F, 
total n = 13; IKKF/F, n = 18; IKKIEC, n = 12; and 
IKKIEC mice, n = 16). Data for f are pooled from 
three independent experiments. Data are shown as 
mean ± SEM. † indicates infection-induced mortal-
ity. *, P < 0.05 compared with IKKF/F.
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protein (Fig. 2 a) and mRNA (Fig. 2 b) expression was signifi-
cantly reduced in IKKIEC mice in the steady state. This cor-
related with significant reductions in the mRNA expression 
levels of the IL-22–dependent AMPs Reg3g and Reg3b in the 
colon in the absence of IEC-intrinsic IKK expression (Fig. 2 b). 
To assess whether the expression of IL-22 and AMPs was com-
promised after C. rodentium infection, we infected IKKF/F 
control and mutant IKKIEC mice with C. rodentium and ana-
lyzed mice at day 4 p.i., an early time point where IL-22 re-
sponses reach their peak after C. rodentium infection (Zheng 
et al., 2008; Ota et al., 2011; Sonnenberg et al., 2011b; Manta 
et al., 2013). Importantly, infection-induced IL-22 protein 
(Fig. 2 c) and mRNA (Fig. 2 d) expression was reduced in 
IKKIEC mice, with concurrent significant reductions in Reg3g 
and Reg3b expression (Fig. 2 e). Together, these data highlight 
that IEC-intrinsic IKK expression regulates both steady state 
and infection-induced IL-22 responses in the colon, suggest-
ing a potential mechanism by which IECs may regulate bar-
rier integrity in the intestine.
Therapeutic delivery of recombinant IL-22 is sufficient to 
rescue IKKIEC mice from C. rodentium–induced morbidity
IL-22 is critical for innate immunity to infection with C. ro­
dentium (Zheng et al., 2008; Satoh-Takayama et al., 2008; Kiss 
et al., 2011; Sonnenberg et al., 2011b; Tumanov et al., 2011). 
In response to C. rodentium infection, IL-22–deficient mice 
exhibit rapid weight loss, intestinal barrier breakdown, and 
impaired control of bacterial dissemination resulting in death 
(Zheng et al., 2008), a phenotype consistent with C. rodentium–
infected IKKIEC mice (Fig. 1). Epithelial cells possess an 
survived beyond day 12 p.i. were able to resolve the infection 
and regain weight at a similar level to that of control mice (not 
depicted). Histological analyses demonstrated that deletion of 
IKK or IKK in IECs was not associated with altered intes-
tinal immune homeostasis in the steady state (Fig. 1 g), con-
sistent with a previous study (Nenci et al., 2007). However, 
although C. rodentium–infected IKKF/F, IKKIEC, and 
IKKF/F mice exhibited modest intestinal inflammation at 
day 11 p.i. (Fig. 1 h), infected IKKIEC mice exhibited severe 
inflammation, characterized by disruption of normal epithelial 
crypt architecture, mucosal hyperplasia, and colonic ulceration 
(Fig. 1 h), resulting in a significantly higher colonic pathology 
score relative to control mice (Fig. 1 i). Associated with a loss 
of intestinal barrier integrity and bacterial dissemination, 
neutrophil-rich inflammatory foci were observed in the liver 
of IKKIEC mice at day 11 p.i. (Fig. 1 j). Collectively, these 
data highlight the selective requirement for IEC-intrinsic ex-
pression of IKK for regulation of antibacterial immune re-
sponses and intestinal barrier homeostasis.
Colonic IL-22 and AMP expression are reduced in IKKIEC 
mice in the steady state and after C. rodentium infection
To investigate the mechanisms for dysregulated C. rodentium–
induced intestinal inflammation in IKKIEC mice, we first 
examined the expression levels of key cytokines involved in 
immunity to C. rodentium. Compared with littermate control 
IKKF/F mice, protein levels of the proinflammatory cytokine 
IFN were significantly elevated in the colons of naive 
IKKIEC mice, whereas expression levels of IL-17A and IL-6 
were not significantly different (Fig. 2 a). In contrast, IL-22 
Figure 2. Colonic IL-22 and AMP expression is reduced in IKKIEC mice in the steady state and after C. rodentium infection. (a) IFN, IL-17A, 
IL-6, and IL-22 protein expression in colonic tissue homogenates from naive littermate control IKKF/F and IKKIEC mice, as measured by ELISA. (b) Il22, 
Reg3g, and Reg3b mRNA expression in colonic tissue homogenates from naive mice, as measured by RT-PCR. (c–e) IKKF/F or IKKIEC mice were infected 
with C. rodentium, and IL-22 protein expression (c) and Il22 mRNA (d) were measured in colonic tissue homogenates of naive (N) or infected (INF) mice at 
day 4 p.i. (e) Reg3g and Reg3b mRNA expression in colonic tissue homogenates from naive or day 4 C. rodentium–infected mice. Gene expression data in 
b, d, and e were normalized to naive IKKF/F mice. Data for a and b are representative of two independent experiments (IKKF/F, total n = 9; IKKIEC, n = 8).  
Data for c–e are representative of three independent experiments (IKKF/F, total n = 15; IKKIEC, n = 14 + 1 naive mouse of each genotype per experi-
ment). Data are expressed as mean ± SEM. *, P < 0.05 compared with IKKF/F control.
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mice are a likely cause of C. rodentium–induced morbidity 
and mortality.
C. rodentium infection–induced ILC-dependent IL-22 
responses are diminished in IKKIEC mice
IL-22 can be produced by a variety of immune cells, includ-
ing T cells, ILCs, neutrophils, and DCs (Zheng et al., 2008; 
Sonnenberg et al., 2011a; Zindl et al., 2013). However, previ-
ous studies have demonstrated that ILC3-dependent IL-22 
responses are critical for innate immunity to C. rodentium in-
fection (Sonnenberg et al., 2011b; Manta et al., 2013). Con-
sistent with this, analysis of the predominant IL-22–expressing 
cells in the early stages of C. rodentium infection (day 4 p.i.) 
demonstrated that lineage-negative cells were the predomi-
nant source of IL-22 in the mesenteric LNs (mLNs) of control 
IKKF/F mice (Fig. 4, a and b). Further characterization revealed 
that IL-22–expressing CD3CD5NK1.1 cells expressed 
RORt, CD25, CD90, and CD4, a phenotype consistent with 
that of ILC3s (Fig. 4 c). Analysis of RORt+ ILC responses 
(lineage, RORt+, CD25+ cells) in the mLNs of naive and 
day 4 C. rodentium–infected IKKF/F and IKKIEC mice re-
vealed that although the frequencies of intestinal RORt+ ILCs 
were not significantly different (Fig. 4 d), total numbers of 
RORt+ ILCs were significantly reduced in C. rodentium–
infected IKKIEC mice compared with IKKF/F control 
(Fig. 4 e). Strikingly, when RORt+ ILCs were assessed for 
array of mechanisms by which they can control mucosal im-
munity, and epithelial IKK expression may have diverse ef-
fects on intestinal immune homeostasis beyond regulating 
IL-22 responses. To determine whether delivery of exoge-
nous IL-22 was sufficient to restore protective immunity in 
IKKIEC mice, IKKIEC mice were infected with C. roden­
tium and treated with either PBS or rIL-22 every other day. 
Although IKKIEC mice treated with PBS exhibited ele-
vated bacterial titers in the feces at day 6 p.i. (Fig. 3 a) and 
enhanced bacterial dissemination to the liver at day 12 p.i. 
(Fig. 3 b) compared with control IKKF/F mice, rIL-22–treated 
IKKIEC mice displayed significant reductions in bacterial 
burdens (Fig. 3, a and b), indicating restoration of host- 
protective immunity. Consistent with this, although PBS-
treated IKKIEC mice underwent significant weight loss 
and infection-induced mortality, therapeutic administration 
of rIL-22 to IKKIEC mice rescued mice from infection-
induced weight loss and fatal C. rodentium infection (Fig. 3, 
c and d). Restoration of host-protective immunity corre-
lated with reductions in colonic histopathology at day 12 
p.i. (Fig. 3 e), lower colonic pathology score (Fig. 3 f ), and 
reduced neutrophilic infiltrates in the liver at day 12 p.i. in 
rIL-22–treated IKKIEC mice (Fig. 3 g). These data indicate 
that delivery of exogenous IL-22 is sufficient to restore an-
tibacterial immunity in mice with IEC-specific deletion of 
IKK, suggesting that defective IL-22 responses in IKKIEC 
Figure 3. Therapeutic delivery of recombinant IL-22 is sufficient to rescue IKKIEC mice from C. rodentium–induced morbidity. IKKIEC 
mice were infected with C. rodentium and injected i.p. with either PBS or 50 µg rIL-22 every 2 d (littermate control IKKF/F mice received PBS 
only). (a and b) C. rodentium CFU in the feces on day 5 p.i. (a) and liver on day 12 p.i (b). (c and d) Percentage of initial body weight (c) and percent sur-
vival (d) at the indicated time points p.i. Data are pooled from three identical experiments. (e) H&E staining of colon tissue sections of C. rodentium–
infected mice at day 12 p.i. (f) Pathological score of colon histology. (g) H&E staining in liver tissue sections of infected mice at day 12 p.i. Arrows indicate 
neutrophil-rich inflammatory foci. All bars, 50 µm. Data are representative of three independent experiments (IKKF/F + PBS total n = 14; IKKIEC + PBS, 
n = 14; IKKIEC + rIL-22, n = 12) and expressed as mean ± SEM. *, P < 0.05. ND, not detected. † indicates infection-induced mortality.
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of producing IL-22 if provided with adequate exogenous stim-
uli, and although the frequency of IL-22–producing ILC3s 
tended to be lower in rIL-23–stimulated cultures of IKKIEC 
cells than cells from IKKF/F mice (Fig. 4 g), these differences 
did not reach statistical significance. Importantly, frequencies of 
CD4+ T cells expressing IL-22 were not significantly altered in 
their functional capacity to produce IL-22 after PMA and ion-
omycin stimulation, we observed a significant reduction in 
infection-induced IL-22 responses in RORt+ ILCs from 
IKKIEC mice compared with IKKF/F littermate controls 
(Fig. 4 f ). Stimulation of cells with rIL-23 ex vivo revealed that 
RORt+ ILCs from IKKIEC mice were functionally capable 
Figure 4. C. rodentium infection–induced ILC-dependent IL-22 responses are diminished in IKKIEC mice. IKKF/F mice were infected (INF) 
with C. rodentium and sacrificed at day 4 p.i. (a) Representative plots displaying frequencies of IL-22+ cells in the mLNs. (b) Expression of T cell (CD3 and 
CD5) and NK cell (NK1.1) markers among IL-22+ cells. (c) Expression of ILC surface markers in gated CD3CD5NK1.1IL-22+ cells (black, open histo-
grams) compared with CD19+ B cells (gray, closed histograms). (d) Representative plots displaying frequencies of CD3CD5CD19CD11cNK1.1, 
RORt+CD25+ ILCs in the mLNs of naive and C. rodentium–infected littermate control IKKF/F and IKKIEC mice. (e) Total mLN ILC3s. (f) Frequencies of 
IL-22–expressing RORt+ ILCs in the mLN after ex vivo PMA and ionomycin stimulation. (g) Frequencies of IL-22–expressing RORt+ ILCs in the mLNs 
after stimulation with rIL-23, PMA, and ionomycin. (h) Frequencies of CD3+CD4+ T cells in the mLNs expressing IL-22 after ex vivo PMA and ionomycin 
stimulation. Data for a–f and h are representative of five experiments (IKKF/F, total n = 21; IKKIEC, n = 17 + 1 naive mouse of each genotype per ex-
periment), and data for g are representative of three experiments (IKKF/F, total n = 13; IKKIEC, n = 11 + 1 naive mouse of each genotype per experi-
ment). Data are expressed as mean ± SEM. *, P < 0.05 compared with IKKF/F INF.
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and cytokine production before adoptive transfer into recipi-
ent IKKF/F or IKKIEC mice. Although IKKIEC mice 
that received T cells exhibited elevated bacterial titers in the 
feces at day 12 p.i. (Fig. 5 a) and exacerbated colonic inflam-
mation and histology score compared with IKKF/F control 
mice (Fig. 5, b and c), IKKIEC mice that received cyto-
kine-activated ILCs displayed significantly reduced bacterial 
burdens (Fig. 5 a) and improved intestinal pathology and co-
lonic histology score at day 12 p.i. (Fig. 5, b and c), indicat-
ing that ILCs were more potent at restoring antibacterial 
immunity than T cells. To examine the cell-intrinsic mech-
anism by which ILCs confer protection against C. rodentium 
infection, analogous experiments were performed where 
recipient IKKF/F or IKKIEC mice were injected with ei-
ther sort-purified ILCs or T cells from C57BL/6 WT mice 
or ILCs from C57BL/6 Il22/ mice. Although IL-22–
competent T cells were unable to confer protection against 
IKKIEC mice (Fig. 4 h), indicating that IKK-dependent 
regulation of IL-22 expression may be selective for ILCs. 
Collectively, these data indicate that IEC-intrinsic IKK ex-
pression is necessary for optimal C. rodentium infection– 
induced ILC3-dependent IL-22 responses.
Delivery of sort-purified IL-22–competent ILCs restores 
immunity to C. rodentium infection in IKKIEC mice
Although RORt+ ILCs are the primary source of IL-22 in 
response to C. rodentium infection (Fig. 4, b and c), cells other 
than ILCs may contribute to IL-22–mediated immunity to 
C. rodentium. Therefore, we next assessed whether transfer of 
ILCs alone could restore immunity to C. rodentium infection 
in IKKIEC mice. To do so, ILCs (lineageCD90+CD25+
CD127+) or T cells (CD3+CD90+) were sort purified from 
naive littermate control IKKF/F mice and pulsed for 1 h ex vivo 
with rIL-23, rIL-1, rIL-2, and rIL-7 to promote survival 
Figure 5. Delivery of sort-purified IL-22–competent ILCs restores immunity to C. rodentium infection in IKKIEC mice. (a–c) IKKIEC mice 
were infected with C. rodentium and injected i.v. with either 104 sort-purified CD90+CD3+ T cells or 104 sort-purified lineageCD90+CD25+CD127+ ILCs 
from IKKF/F mice on days 0, 2, 4, and 7 p.i. (littermate control IKKF/F mice received T cells only). T cells and ILCs were pulsed with rIL-23, rIL-1, rIL-2, 
and rIL-7 for 1 h before injection. (a) C. rodentium CFU in the feces on day 6 p.i. (b) H&E staining of colon tissue sections at day 12 p.i. (c) Pathological 
score of colon histology. (d–f) Littermate IKKF/F and IKKIEC mice were infected with C. rodentium and injected i.v. with either 104 sort-purified T cells or 
104 sort-purified ILCs (gating strategies as per a–c) from either C57BL/6 WT or C57BL/6 Il22/ mice on days 0, 2, 4, and 7 p.i. (d) C. rodentium CFU in the 
feces on d 6 p.i. (e) H&E staining of colon tissue sections at day 12 p.i. All bars, 50 µm. (f) Pathological score of colon histology. Data for a–c are represen-
tative of two independent experiments (IKKF/F + T cells, n = 8; IKKIEC + T cells, n = 8; IKKIEC + ILCs, n = 6). Data for d–f are representative of two 
experiments (IKKF/F + WT T cells, n = 7; IKKIEC + WT T cells, n = 7; IKKIEC + WT ILCs, n = 6; IKKIEC + IL-22/ ILCs, n = 6). Data are expressed as 
mean ± SEM. *, P < 0.05.
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et al., 2002). Notably, analysis of other IEC-intrinsic factors 
that may regulate ILC function revealed elevated expression 
of TSLP mRNA (Fig. 6 b) that correlated with significantly 
increased Tslp mRNA and TSLP protein levels in whole co-
lonic tissue homogenates (Fig. 6 c).
TSLP acts as a negative regulator of ILC-derived  
IL-22 production
Although TSLP has been shown to regulate the function of 
ILC2s (Mjösberg et al., 2012; Kim et al., 2013), a role for 
TSLP in influencing other ILC subsets has not been described. 
To assess whether TSLP regulates ILC3 function, we cultured 
splenocytes from WT C57BL/6 mice overnight with various 
concentrations of rTSLP, followed by 3-h stimulation with 
rIL-23, and examined IL-22 expression. Critically, although 
rIL-23 induced potent IL-22 expression in RORt+ ILCs in 
the absence of TSLP, addition of rTSLP to splenocyte cul-
tures limited IL-22 expression by ILCs in a dose-dependent 
manner (Fig. 7 a), suggesting that TSLP is a negative regulator 
of IL-22 production by ILCs. To assess whether TSLP acts 
directly on ILCs to regulate IL-22 production, we sort purified 
splenic lineageCD90+CD127+ cells from C57BL/6 Rag1/ 
mice and cultured cells overnight with various concentra-
tions of rTSLP, followed by 3-h stimulation with rIL-23, 
and examined IL-22 expression. Notably, rIL-23 was able to 
induce equivalent IL-22 production in ILCs in the presence 
or absence of rTSLP, suggesting that the ability of TSLP to 
inhibit IL-22 production is indirect (Fig. 7 b). Next, we ex-
amined whether TSLP could regulate ILC–IL-22 responses 
in vivo. Hydrodynamic tail vein injection with gene-encoding 
plasmids has been used to induce protein overexpression in 
several settings (Sebestyén et al., 2006). Here, we treated 
C57BL/6 WT mice with either a control or TSLP overexpress-
ing cDNA plasmid (as we have previously reported [Siracusa 
et al., 2011, 2013; Kim et al., 2013; Noti et al., 2014]), which 
has been shown to elevate circulating TSLP levels (Iseki et al., 
2012), and examined IL-22 expression in ILCs 9 d later. Con-
sistent with our in vitro findings using rIL-23 stimulation, TSLP 
overexpression led to diminished IL-22 production by RORt+ 
ILCs isolated from the colonic lamina propria lymphocytes 
(cLPLs), mLNs, and spleen (Fig. 7 c), corresponding with 
significantly reduced expression levels of colonic Reg3g and 
Reg3b (Fig. 7 d). We next performed loss of function experi-
ments to examine whether TSLP regulates innate immunity to 
C. rodentium. C57BL/6 Rag1/ mice are highly susceptible to 
C. rodentium infection; however, IL-22 from ILCs does con-
tribute to innate immunity (Zheng et al., 2008; Sonnenberg 
et al., 2011b). Although C57BL/6 Rag1/ mice exhibited sig-
nificant weight loss (Fig. 7 e) and succumbed to C. rodentium 
infection by days 20–22 p.i. (Fig. 7 f), C57BL/6 Rag1/ mice 
deficient in TSLP responsiveness (Rag1/Tslpr/ mice) lost 
less weight, and this correlated with prolonged survival, only 
succumbing to infection between days 45 and 65 p.i. (Fig. 7, 
e and f). Collectively, these data suggest that TSLP negatively 
regulates innate immunity to C. rodentium, potentially via reg-
ulation of the ILC3–IL-22 axis.
C. rodentium infection in IKKIEC mice, transfer of IL-22–
competent ILCs reduced fecal bacterial titers (Fig. 5 d) and 
intestinal pathology (Fig. 5, e and f) in IKKIEC mice. 
Critically, Il22/ ILCs were unable to confer similar pro-
tection (Fig. 5, d–f). Collectively, these data indicate that 
the provision of IL-22–competent ILCs is sufficient to re-
store immunity to C. rodentium infection in IKKIEC mice, 
providing further evidence that defective ILC3–IL-22 re-
sponses are a likely cause of C. rodentium–induced immuno-
pathology in IKKIEC mice.
IKKIEC mice exhibit dysregulated TSLP expression  
by colonic IECs
We next assessed the mechanisms by which IKK expression 
within IECs regulates IL-22 production by ILC3. Production 
of IL-22 by intestinal ILCs is promoted by IL-23, IL-1, 
IL-2, LT12, and Ahr ligands (Cella et al., 2009; Hughes 
et al., 2010; Kiss et al., 2011; Reynders et al., 2011; Kinnebrew 
et al., 2012; Lee et al., 2012), whereas IEC-derived IL-25 is 
a negative regulator of ILC responses in the intestine (Sawa 
et al., 2011). Analysis of cytokine expression in whole colonic 
tissue isolated from day 4 C. rodentium–infected IKKIEC 
versus littermate control IKKF/F mice revealed no significant 
differences in expression of Il23a, Il1b, Tgfb, Il2, Il25, or Ltb 
mRNA (Fig. 6 a). Colonic IECs were isolated, and as expected, 
gene expression of the LTR-dependent chemokines Cxcl1 and 
Ccl20 were significantly diminished in IECs from IKKIEC 
mice (Fig. 6 b), given that LTR signals through the nonca-
nonical NFB pathway (Matsushima et al., 2001; Dejardin 
Figure 6. IKKIEC mice exhibit dysregulated TSLP expression by 
colonic IECs. (a–c) Littermate IKKF/F and IKKIEC mice were infected 
with C. rodentium and sacrificed at day 4 p.i. (a) Relative mRNA expres-
sion of Il23a, Il1b, Tgfb, Il2, Il25, and Ltb in colon tissue homogenates. 
(b) Relative Cxcl1, Ccl20, and Tslp mRNA expression levels in colonic 
IECs. (c) Tslp mRNA and TSLP protein levels in colonic tissue homog-
enates. Gene expression data were normalized to naive IKKF/F mice. 
Data for a and c are representative of three independent experiments 
(IKKF/F, total n = 15; IKKIEC, n = 14). Data for b is representative of 
two experiments (IKKF/F, total n = 10; IKKIEC, n = 8). Data are ex-
pressed as mean ± SEM. *, P < 0.05.
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neutralization of TSLP in IKKIEC mice increased IL-22 
production by splenic ILC3 at day 4 p.i. (Fig. 8 e) and restored 
IL-22 production in the colon to levels observed in IKKF/F 
mice (Fig. 8 f ). These data demonstrate that dysregulated 
TSLP expression in the absence of IEC-intrinsic IKK ex-
pression is a potential mechanism by which ILC-dependent 
innate immunity to C. rodentium is impaired in IKKIEC mice.
IEC-intrinsic IKK expression regulates inflammation during 
chemically induced intestinal damage
To assess whether IKK expression within IECs is protective 
in other models of intestinal inflammation, we examined the 
susceptibility of IKKF/F mice and IKKIEC mice to dextran 
sodium sulfate (DSS)–induced colitis. Inclusion of 3% DSS 
in the drinking water of control IKKF/F mice caused only 
Neutralization of TSLP partially restores immunity  
to C. rodentium infection in IKKIEC mice
To directly assess whether overexpression of TSLP in IKKIEC 
mice is responsible for impaired immunity to C. rodentium 
infection, we treated IKKIEC mice every 3 d p.i. with either 
a neutralizing anti-TSLP mAb or a control rat IgG. Litter-
mate control IKKF/F mice received rat IgG only. Critically, 
although IKKIEC mice treated with rat IgG displayed in-
creased C. rodentium CFU in the feces at day 6 p.i. (Fig. 8 a) 
and liver at day 11 p.i. (Fig. 8 b) compared with IKKF/F 
mice, IKKIEC mice treated with anti-TSLP mAb exhibited 
substantially reduced bacterial titers (Fig. 8, a and b). TSLP 
neutralization also partially protected IKKIEC mice from 
infection-induced weight loss (Fig. 8 c) and diminished colonic 
pathology (Fig. 8 d). Importantly, antibody (Ab)-mediated 
Figure 7. TSLP acts as a negative regulator of ILC-
derived IL-22 production. (a) C57BL/6 WT mouse spleno-
cytes were cultured overnight in the presence of increasing 
doses of rTSLP and stimulated for 3 h with rIL-23 or were 
left unstimulated (NO STIM), and intracellular IL-22 expres-
sion was assessed in lineageRORt+CD90+ ILC popula-
tions. (b) ILCs were sort purified from C57BL/6 Rag1/ 
mice and cultured overnight in the presence of rTSLP, fol-
lowed by 3-h stimulation with rIL-23 or medium (NO STIM), 
and intracellular IL-22 expression was assessed. (c and d) 
WT C57BL/6 mice were injected with either a control cDNA 
plasmid or a TSLP-overexpressing cDNA plasmid for 9 d, 
and (c) IL-22 production by RORt+ ILCs in the cLPLs, mLNs, 
and spleen was assessed after 3-h stimulation with rIL-23 
in the presence of brefeldin A. (d) Reg3g and Reg3b mRNA 
expression in colonic tissue homogenates. (e and f) 
C57BL/6 Rag1/ or double mutant Rag1/Tslpr/ mice 
were infected with C. rodentium. Percentage of initial body 
weight (e) and percent survival (f) at the indicated time 
points p.i. Data for a and b are representative of two inde-
pendent experiments (total n = 6/treatment), data for c and d 
are representative of two experiments (total n = 6/group), 
and data for e and f are representative of two experiments 
(Rag1/, n = 10; Rag1/Tslpr/, n = 8). Data are expressed 
as mean ± SEM. *, P < 0.05.
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controls (Fig. 9 d). In line with increased pathology in IKKIEC 
DSS-treated mice, levels of the proinflammatory cytokines 
IFN and IL-17A were elevated in IKKIEC mice at day 4 
after DSS treatment (Fig. 9 e). Consistent with what was ob-
served after C. rodentium infection, IL-22 protein levels were 
significantly reduced in the colon of DSS-treated IKKIEC 
mice compared with littermate IKKF/F controls (Fig. 9 e). 
In conclusion, IEC-intrinsic IKK expression can limit inflam-
mation in experimental models of infection-induced colitis 
and chemical-induced intestinal inflammation.
DISCUSSION
RORt+ ILCs are central for regulation of immunity and barrier 
function in the intestine by promoting secondary lymphoid 
structure formation (Kiss et al., 2011), preventing bacterial 
dissemination (Sonnenberg et al., 2012), controlling immune 
responses to commensal microbes (Hepworth et al., 2013, 
2015), and regulating epithelial cell homeostasis in health and 
disease (Ota et al., 2011; Sawa et al., 2011; Sonnenberg et al., 
2011b; Hanash et al., 2012; Qiu et al., 2012; Kirchberger et al., 
2013; Goto et al., 2014). Although several studies have identi-
fied some of the transcription factors, microbial factors, and 
cytokines involved in the development and function of ILC3s 
(Cording et al., 2014), the cellular and molecular network in-
volved in regulation of ILC3s remains incompletely defined. 
The present study identifies a previously unappreciated path-
way by which IECs selectively regulate ILC3 function via IKK 
expression. Ablation of IKK, but not IKK, expression within 
IECs led to impaired antibacterial immunity and compromised 
intestinal barrier function that was associated with defective 
IL-22 production by ILC3s. Immunity to C. rodentium could 
be restored by therapeutic administration with rIL-22 or with 
ILCs from IL-22–competent mice that had been pre-primed 
for IL-22 production. Absence of IKK expression by IECs 
led to the overexpression of TSLP, a cytokine that we demon-
strate can suppress ILC3-derived IL-22 production in vitro 
and inhibit innate immunity to C. rodentium infection in vivo. 
Together, these findings highlight a previously unrecognized 
mechanism of immune–epithelial cell dialogue that regulates 
intestinal barrier homeostasis, tissue protection, and antimi-
crobial ILC3 responses.
The NFB signaling pathway is fundamental for regulation 
of IEC function, and although absence of individual IKK 
and IKK subunits does not result in spontaneous inflamma-
tion (Nenci et al., 2007), IEC-intrinsic IKK expression is criti-
cal for limiting intestinal inflammation in chemically induced 
models of colitis (Eckmann et al., 2008), ischemia-reperfusion 
injury (Chen et al., 2003), and helminth infection (Zaph et al., 
2007). Furthermore, overexpression of IKK within IECs 
results in uncontrolled epithelial proliferation and intestinal 
tumorigenesis (Guma et al., 2011; Vlantis et al., 2011). In the 
present study, we identify a critical role for IKK-mediated 
signaling pathways in regulating C. rodentium–induced colitis 
and demonstrate that IKK is dispensable, representing the 
first demonstration of a differential requirement for IKK- 
versus IKK-dependent gene expression on IEC function. 
modest weight loss, increased disease severity score, and colon 
shortening (Fig. 9, a–c) compared with mice that received 
normal drinking water (naive). However, IKKIEC mice ex-
perienced rapid weight loss from day 5 after DSS feeding 
(Fig. 9 a) and had to be sacrificed by day 6 because of escalat-
ing disease severity (Fig. 9 b). IKKIEC mice displayed exac-
erbated colonic shortening (Fig. 9 c) and markedly increased 
colonic immunopathology compared with IKKF/F littermate 
Figure 8. Neutralization of TSLP partially restores immunity to  
C. rodentium infection in IKKIEC mice. IKKIEC mice were infected with 
C. rodentium and injected i.p. with either 0.5 mg rat IgG control or anti-
TSLP mAb every 3 d (littermate control IKKF/F mice received rat IgG only). 
(a and c) C. rodentium CFU in the feces on day 6 p.i. (a) and liver on day 11 p.i. 
(b). (c) Percentage of initial body weight. (d) H&E staining of colon tissue 
sections of day 11 C. rodentium–infected mice. Bar, 50 µm. (e) IL-22 
expression by splenic ILCs at day 4 p.i., after ex vivo PMA and ionomycin 
stimulation. (f) IL-22 protein expression within colon homogenate tissue 
from day 4 infected mice. Data for a–d are representative of three experi-
ments (IKKF/F + rat IgG, n = 13; IKKIEC + rat IgG, n = 10; IKKIEC + 
anti-TSLP, n = 9), and data for e and f are representative of two experi-
ments (IKKF/F + rat IgG, n = 8; IKKIEC + rat IgG, n = 6; IKKIEC + anti-
TSLP, n = 6). Data are expressed as mean ± SEM. *, P < 0.05 compared 
with IKKIEC + rat IgG.
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expression of IL-25 has been reported to suppress ILC3 re-
sponses (Sawa et al., 2011). Although we did not observe sig-
nificant increases in IL-25 in IKKIEC mice, expression of 
the predominately IEC-derived cytokine TSLP was exagger-
ated in these mice. We demonstrate that exogenous TSLP 
suppressed IL-22 production by RORt+ ILC3s in vitro and 
in vivo and that Ab-mediated neutralization of TSLP could 
partially restore innate immunity to C. rodentium infection in 
IKKIEC mice. These data indicate that in addition to IL-25, 
TSLP acts as a negative regulator of ILC3 function in the con-
text of bacterial-driven intestinal inflammation. Further stud-
ies are needed to illuminate whether additional IEC-dependent 
mechanisms, such as growth factors or the intestinal microbi-
ota, may regulate ILC3 location, accumulation, or function.
Previous studies have demonstrated interactions between 
TSLP and ILC2s (Mjösberg et al., 2012; Kim et al., 2013) 
and that TSLPR signaling is dispensable for ILC3 develop-
ment (Vonarbourg et al., 2010). How TSLP regulates IL-22 
production by ILC3s remains unclear, but our data suggest 
that TSLP acts indirectly on ILCs to exert its function, possi-
bly via an accessory TSLP-responsive cell such as a DC. It is 
becoming increasingly evident that TSLP has diverse cellular 
targets and biological functions, where TSLP may play both 
tissue-protective roles in the intestine (e.g., regulation of DC, 
ILC2, and granulocyte function; Ziegler et al., 2013), as well 
as nonprotective functions as illustrated in the current study. 
Thus, it remains possible that the protective effects we ob-
served after TSLP neutralization during C. rodentium infec-
tion may be distinct from what would occur in DSS colitis 
where blocking TSLP–TSLPR interactions has been shown 
to exacerbate disease (Taylor et al., 2009; Reardon et al., 2011). 
Furthermore, it is unknown how and why TSLP expression 
by IECs is dysregulated in the absence of IKK signaling. 
Given that TSLP is an IKK-dependent gene product (Lee 
and Ziegler, 2007; Zaph et al., 2007) and that the absence of 
Furthermore, our findings are consistent with a previous 
study demonstrating that hyperactivation of the noncanonical 
NFB pathway is associated with elevated immunity to C. ro­
dentium (Hu et al., 2013), suggesting a pivotal role for IKK-
dependent signaling in immunity to bacterial infection.
IKK-dependent noncanonical NFB activation is asso-
ciated with LTR signaling (Schneider et al., 2004), and LTR is 
a critical regulator of intestinal ILC-dependent IL-22 responses 
(Ota et al., 2011; Tumanov et al., 2011; Macho-Fernandez et al., 
2015). Furthermore, mice with IEC-specific deletions in LTR 
are highly susceptible to C. rodentium infection (Wang et al., 
2010). Together, these data indicate a potential role for impaired 
LTR signaling contributing to a reduction in host-protective 
immunity to C. rodentium in IKKIEC mice. However, LT-
mediated regulation of ILCs was primarily mediated through 
DCs, and the impact of IEC-specific LTR deletion on ILCs 
and IL-22 was not assessed (Wang et al., 2010). We did observe 
significant reductions in expression of the LTR-dependent 
genes Cxcl1 and Ccl20 in IECs recovered from IKKIEC 
mice; hence it remains plausible that defective LTR signaling 
may contribute to impaired IL-22 responses in the absence of 
IEC-intrinsic IKK expression. This is consistent with a recent 
study showing that IEC-intrinsic LTR expression regulates 
IL-22–dependent intestinal immune homeostasis during chemi-
cally induced colitis (Macho-Fernandez et al., 2015). Notably, 
despite impaired LTR-dependent gene expression in IKKIEC 
mice, we did not observe reductions in the presence of intes-
tinal lymphoid tissues such as Peyer’s patches (PPs) or isolated 
lymphoid follicles in IKKIEC mice (unpublished data), sug-
gesting that in this context, other LT-responsive cells may 
have coordinated lymphoid organogenesis.
IL-22 production by ILC3s can be stimulated by several fac-
tors, chiefly IL-23 and IL-1, but expression of these cytokines 
was not altered in IKKIEC mice. In addition to factors that posi-
tively regulate ILC3 function, commensal bacteria–dependent 
Figure 9. IEC-intrinsic IKK expression 
regulates inflammation and pathology 
during chemically induced colitis. Litter-
mate IKKF/F and IKKIEC mice were treated 
with either 3% DSS in the drinking water or 
maintained on normal drinking water (naive, N). 
(a) Percentage of original body weight.  
(b) Gross disease score. (c) Colon length at 
day 6 after DSS. (d) H&E staining of colon 
tissue sections of naive and DSS-treated 
mice at day 6 after DSS. Bar, 50 µm. (e) IFN, 
IL-17A, and IL-22 protein expression in over-
night colonic organ culture supernatants at 
day 4 after DSS. Data for a–d are representa-
tive of three independent experiments 
(IKKF/F, n = 17; IKKIEC, n = 14 + 2 naive of 
each genotype per experiment). Data for  
e are representative of two independent ex-
periments (IKKF/F, n = 8; IKKIEC, n = 8 + 2 
naive of each genotype per experiment). 
Data are expressed as mean ± SEM. *, P < 
0.05 compared with IKKF/F + DSS.
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Hepworth et al., 2015), indicates that targeted manipulation 
of the IEC–ILC axis could be beneficial for the treatment of 
chronic intestinal inflammatory disorders.
MATERIALS AND METHODS
Animals, cell isolations, and treatments. IKKF/F (Liu et al., 2008) and 
IKKF/F (Pasparakis et al., 2002) mice used in this study were on a mixed ge-
netic background and crossed with C57BL/6 villin-Cre mice (Pasparakis et al., 
2002) to generate littermate controls and IKKIEC and IKKIEC mouse 
strains as described previously (Greten et al., 2004; Nenci et al., 2007). Mice 
were bred at the University of Pennsylvania or Weill Cornell Medical College 
and maintained in a specific pathogen–free environment. Male or female mice 
between the ages of 6 and 14 wk were used. Only cohoused littermate controls 
were used in experiments with F/F and IEC mice. In some other experi-
ments, C57BL/6 wild-type mice were used and obtained from the Jackson 
Laboratory. C57BL/6 Il22/, Rag1/, and Tslpr/ mice were bred in-
house. Experiments were terminated when mice lost a significant proportion 
of their original weight (>20%); however, mice that succumbed to infection 
died naturally. All experiments were performed according to guidelines of the 
Cornell University or University of Pennsylvania Institutional Animal Care 
and Use Committee–approved protocols. At necropsy, single cell suspensions 
of mLNs or PPs were prepared by passing through 70-µm nylon mesh filters. 
Splenocytes were isolated by homogenization followed by red blood cell lysis. 
IECs were isolated by thoroughly washing colon tissue in PBS and incubating 
for 10 min at 37°C with 5 ml of a 5 mM EDTA in PBS solution, shaking. The 
epithelial layer was then removed and passed through a 70-µm cell strainer. 
cLPLs were isolated as previously described (Zaph et al., 2007). Recombinant 
IL-22 (Pfizer), 50 µg/mouse in PBS, was injected i.p. into mice on days 0, 2, 
4, 6, 8, and 10 after C. rodentium infection. Mice were injected i.v. by hydro-
dynamic tail vein injection with 10 µg control or TSLP encoding cDNA plas-
mid (Siracusa et al., 2011, 2013; Iseki et al., 2012; Kim et al., 2013; Noti et al., 
2014). Previous studies have demonstrated that hydrodynamic injections with 
similar cDNA constructs have resulted in incorporation and gene expression 
primarily within hepatocytes (Yang et al., 2001; Sebestyén et al., 2006; Suda 
and Liu, 2007). Mice were treated with neutralizing mAb against mouse TSLP 
(Amgen) by i.p. injection with 0.5 mg Ab 4 h before infection and every 3 d 
p.i. Control mice received equivalent amounts of rat IgG.
Adoptive transfer of sort-purified ILCs. ILCs (CD3CD19CD11c
NK1.1CD90+CD127+CD25+) were sort purified from the spleen, PPs, 
and mLNs of naive IKKF/F, C57BL/6 WT, or C57BL/6 Il22/ mice using 
a FACSAria III sorter (BD). T cells (CD3+CD90+) were simultaneously sorted 
as a control cell population. Sorted ILCs and T cells were incubated for 1 h 
at 37°C with 10 ng/ml rIL-7, 10 ng/ml rIL-2, 10 ng/ml rIL-23, and 10 ng/ml 
rIL-1 (R&D Systems) to support cell viability and optimal IL-22 produc-
tion before i.v. transfer into recipient IKKIEC or IKKF/F mice on days 0, 
2, 4, and 7 after C. rodentium infection.
C. rodentium infection and assessment of CFU. C. rodentium strain 
DBS100 (provided by B. Vallance, University of British Columbia, Vancou-
ver, British Columbia, Canada) was prepared by selection of a single colony 
and culturing in LB broth overnight. Mice were inoculated with 1010 CFU 
in 200 µl by oral gavage. Analysis of CFU from overnight cultures or me-
chanically homogenized fecal pellets, livers, and spleens was determined via 
serial dilutions on MacConkey agar.
C. rodentium histological analyses and histopathological scoring. Dis-
tal colon and liver were fixed in 4% PFA and embedded in paraffin, and 
5-µm sections were stained with hematoxylin and eosin (H&E). For histo-
logical scoring, colonic tissue sections were blindly graded on a scale of 0–5 
for each of the following parameters: (a) epithelial lesions (crypt elongation, 
hyperplasia, erosion, and ulceration/necrosis), (b) mural inflammation, and 
(c) edema for an overall maximal total histology score of 15.
IKK and IKK can induce compensatory increases in canon-
ical and noncanonical NFB activation, respectively (Lawrence 
et al., 2005; Lam et al., 2008), it is possible that the elevated 
TSLP production in IKKIEC mice is a result of increased 
IKK-dependent canonical NFB activation. Indeed, we did 
observe increased expression of activated phospho-IKK/
IKK (Ser176/177) in colonic IECs from IKKIEC mice com-
pared with IKKF/F mice (unpublished data), although it re-
mains unclear whether this is sufficient to account for increased 
TSLP production.
Although deletion of IKK and IKK within IECs does 
not cause spontaneous colitis (Nenci et al., 2007), the present 
study highlights multiple steady state defects in intestinal im-
mune responses in IKKIEC mice. Absence of IEC-intrinsic 
IKK signaling led to increases in basal IFN expression in 
the intestine, with concurrent reductions in IL-22 and AMP 
expression. It is also possible that IEC-intrinsic NFB signal-
ing regulates the composition of the intestinal microbiota, 
which may have substantial impacts on inflammatory responses, 
but future studies will be required to investigate the interplay 
between immune responses and the microbiota in IKKIEC 
mice. Thus, although IEC-specific deletion of IKK signaling 
does not cause evident pathology in the steady state, develop-
mental defects in these animals likely contributed to impaired 
immunity to infection, as well as increased susceptibility to 
chemically induced colitis. Further studies comparing the rela-
tive roles for IEC-intrinsic IKK and IKK signaling in a va-
riety of other infectious or inflammatory experimental models, 
potentially making use of inducible Cre-lox technology that 
could minimize the impact of altered immune development 
in constitutive IEC mice, will contribute to our understand-
ing of epithelial regulation of host-protective immunity and 
inflammation. In addition, given the multifaceted functions of 
IKK in cell biology (Chariot, 2009), it remains possible that 
the ability of IKK to regulate ILC3-dependent mucosal im-
munity may be independent of its ability to regulate nonca-
nonical NFB activation.
Collectively, these data identify a previously unrecognized 
pathway in which tissue-resident IECs selectively regulate the 
function of ILC3s in an IKK-dependent fashion, thereby si-
multaneously promoting antibacterial immunity and main-
tenance of intestinal immune homeostasis. Elevated NFB 
activation is associated with IBDs in humans, and NFB in-
hibition therapies have been designed to treat multiple intes-
tinal inflammatory diseases (Atreya et al., 2008). However, 
NFB activation can have diverse effects within different cell 
lineages (Greten et al., 2007; Hsu et al., 2011), and humans 
carrying mutations in NFB-related factors such as NOD1 or 
NOD2 develop intestinal inflammation (Strober et al., 2006). 
The present study and a previous one (Greten et al., 2007), 
demonstrate that some factors within the NFB signaling 
pathway are critical for limiting intestinal inflammation, sug-
gesting that more specific targeted therapies may be required 
for the design of optimal therapeutics. This, coupled with 
studies of dysregulated ILC responses in lesions isolated from 
IBD patients (Geremia et al., 2011; Bernink et al., 2013; 
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